November 17, 2026 · Cosmetics and Personal Care
Talc Is Now a CEPA Toxic Substance: What Cosmetic and Natural Health Product Brands in Canada Must Do Next
By Mussarat Fatima

On 4 November 2026, Health Canada and Environment and Climate Change Canada published the Order Adding a Toxic Substance to Part 2 of Schedule 1 to the Canadian Environmental Protection Act, 1999 (SOR/2026-222). With that order, talc, the soft mineral used in loose powders, baby powder, creams and hundreds of personal care products, became a listed toxic substance under Canadian law. The listing does not ban talc, and it does not change a single label overnight. What it does is open the door to the risk management instruments that will follow. For cosmetic, natural health product and non-prescription drug companies, the practical question is no longer whether talc will be regulated, but how soon, and whether your portfolio is ready.
This guide explains what the listing means, which products are in scope, what Health Canada has signalled it will do next, and the concrete steps brands should take now to avoid a reformulation scramble later. Every figure, date and regulatory reference below has been verified against the primary Government of Canada sources.
Executive summary
Is talc banned in Canada?
No. Talc is not banned in Canada. Adding a substance to Schedule 1 of the Canadian Environmental Protection Act, 1999 (CEPA) does not prohibit it, restrict its use or impose any obligation on manufacturers by itself. The Regulatory Impact Analysis Statement that accompanies the order is explicit that orders adding substances to Schedule 1 do not impose regulatory requirements on businesses. The listing is the legal trigger that lets the Minister of Health and the Minister of Environment and Climate Change propose risk management instruments for the substance. Those instruments, not the listing, are where real obligations will appear.
Talc was added to Part 2 of Schedule 1. The distinction between the two parts matters. For Part 1 substances, the ministers must prioritize prohibiting the activities that cause the risk. For Part 2 substances like talc, the ministers prioritize pollution prevention actions when managing the risk, which in some cases may still include a total, partial or conditional prohibition. In plain terms, talc has been flagged as a substance of concern, and the government now has the authority to act on specific uses, but it has chosen a pollution prevention first approach rather than an outright ban.
What exactly changed on 4 November 2026?
The order is short. It adds one line to a list. The substance of the decision sits in the screening assessment and the risk management approach that Health Canada and Environment and Climate Change Canada published earlier in the process. Those documents conclude that talc meets the criteria under paragraph 64(c) of CEPA, meaning it constitutes or may constitute a danger in Canada to human life or health. The screening assessment found that talc does not meet the criteria under paragraphs 64(a) or 64(b), so this is a human health listing, not an environmental one.
This did not arrive without warning. The draft screening assessment and risk management scope were published for a 60-day comment period back in 2018, the final screening assessment and risk management approach followed in 2021, and the proposed order itself was published for comment in 2021. The 4 November 2026 order is the final step that formally lists the substance. If your regulatory affairs team has been tracking the CEPA substances of concern and ingredient checks, none of this is a surprise. If it is a surprise, that is a signal your ingredient watch process has a gap.
Why did Health Canada flag talc?
Two exposure routes drove the decision, and understanding them tells you which of your products are most likely to attract future restrictions.
Inhalation of loose powders
The assessment identified non-cancer lung effects, described as inflammation, impaired lung function and fibrosis, as the critical health effect from breathing in talc. The concern is specific to products used as a loose powder, where fine particles can become airborne and respirable. Health Canada identified the inhalation of talc from the use of baby powder, body powder and loose face powder as posing a potential risk to human health. This risk applies to both males and females.
Female perineal exposure
The second route is perineal, meaning application in the genital area, which the assessment linked to ovarian cancer. The screening assessment described a consistent and statistically significant positive association between perineal exposure to talc and ovarian cancer, and characterised the data as indicative of a causal effect. This concern applies to products used in or near the genital area.
Importantly, the human health assessment found no critical health effects from oral or dermal exposure to talc. That is why pressed powders, which do not release respirable particles the way loose powders do, and products that are simply applied to the skin without a perineal or inhalation pathway, were not identified as a concern. The route of exposure, not the mere presence of talc, is what decides whether a product is in scope.
Which products are affected, and which are not?
Health Canada's risk management approach is targeted. It names specific product categories for each exposure route and is clear that other uses were assessed and not flagged. The table below summarises the government's own findings. Use it as the first filter when you screen your catalogue.
| Exposure route | Product types identified as a potential concern | Health effect of concern |
|---|---|---|
| Inhalation (loose powder) | Baby powder, body powder, loose face powder (cosmetics, natural health products and non-prescription drugs in loose powder form) | Non-cancer lung effects (inflammation, impaired lung function, fibrosis) |
| Female perineal (genital) exposure | Body powder, baby powder, diaper and rash creams, genital antiperspirants and deodorants, body wipes, bath bombs, bubble bath | Association with ovarian cancer |
| Oral and dermal exposure | Not identified as a concern | No critical health effects identified |
| Assessed but not flagged | Foot powder, dry hair shampoo, pressed powder products such as face makeup | Not identified as posing a potential risk |
What is Health Canada planning next?
For cosmetics, the Cosmetic Ingredient Hotlist is the tool Health Canada uses to communicate restrictions and prohibitions. It is an administrative instrument under section 16 of the Food and Drugs Act. The risk management approach proposes to modify the existing talc entry to further reduce exposure from certain cosmetics. The Hotlist entry for talc was already updated in May 2024 to extend cautionary statements for acute inhalation to all cosmetics that contain talc in loose powder form, so companies that sell loose powders should already be carrying those statements.
For natural health products and non-prescription drugs, the approach proposes to modify the existing entries in the Natural Health Products Ingredients Database and the applicable monographs. The NHPID entry for talc was aligned with the cosmetic changes in June 2024. The relevant monographs, including the diaper rash product monograph, already carry cautionary language such as keeping powder away from the face to avoid inhalation. Expect those entries and monographs to be tightened as the risk management instruments are brought forward.
On timing, the risk management approach set out a planned schedule: proposed instruments at the latest within 24 months of the ministers proposing to recommend that talc be added to Schedule 1, and final instruments at the latest within 18 months of the publication of each proposed instrument. Those are planned outer limits, not guarantees, and the exact status of each instrument should be confirmed against the current Canada Gazette and the Chemicals Management Plan schedule before you rely on a date. The safe planning assumption is that proposed Hotlist and NHPID changes are imminent, each will carry a 60-day comment window, and finalisation will follow within roughly a year to 18 months of each proposal.
How big is the exposure for industry?
The regulatory impact analysis estimates that talc is present in approximately 10,000 self-care products on the Canadian market, broken down as roughly 7,750 cosmetics, 2,100 natural health products and 150 non-prescription drugs. That scale is the reason this listing matters commercially. Even if only loose powders and perineal use products are ultimately restricted, the number of affected stock keeping units across the three product classes is significant, and many companies hold talc in formulations they have not reviewed in years.
The three product classes are regulated under different frameworks, so the compliance response differs. Cosmetics are notified through the Cosmetic Notification Form and must comply with the Hotlist and the Cosmetic Regulations. Natural health products require a product licence and must comply with the natural health product regulations and GMP expectations. Non-prescription drugs are governed by the Food and Drug Regulations. A talc reformulation or label change can ripple through notifications, product licence amendments and label artwork across all three.
Talc compliance checklist for Canadian brands
Use this checklist to move from awareness to a defensible position before the risk management instruments land.
- Inventory every stock keeping unit that contains talc across cosmetics, natural health products and non-prescription drugs, including private label and contract manufactured lines.
- Flag each talc-containing product by exposure route and format: loose powder (inhalation), perineal or genital use, or other (lower priority).
- Confirm that loose powder cosmetics already carry the Hotlist cautionary statements for acute inhalation, and that applicable natural health product monographs carry the required cautionary language.
- Check that your Cosmetic Notification Forms and natural health product licences accurately reflect current talc content and concentration.
- Identify reformulation candidates and qualify alternatives such as cornstarch for loose powder products, with stability and performance testing planned in advance.
- Assign an owner to monitor the Canada Gazette and the Chemicals Management Plan schedule for the proposed Hotlist and NHPID instruments and their 60-day comment periods.
- Prepare to submit comments during each consultation so your product realities are on the record before the rules are finalised.
- Map the downstream impact of any change to labels, artwork, notifications, product licence amendments and supplier specifications.
- Document your talc risk assessment and reformulation plan so you can demonstrate due diligence to Health Canada and to retail customers.
Common mistakes to avoid
- Assuming a ban. Treating the Schedule 1 listing as an immediate prohibition leads to panic pulls and lost sales. The listing enables future action, it does not ban talc today.
- Screening by ingredient only. Pulling every talc product ignores the fact that exposure route and format decide scope. Pressed powders and dermal-only products were not flagged.
- Missing the comment periods. Each proposed instrument carries a 60-day consultation. Companies that do not comment lose the chance to shape workable restrictions and transition times.
- Forgetting natural health products and drugs. Many brands think of talc as a cosmetics issue. The listing reaches natural health products and non-prescription drugs through the NHPID and monographs.
- Reformulating without validation. Swapping talc for cornstarch or another filler changes flow, feel and microbial profile. Stability and performance testing must precede a launch, not follow a complaint.
- Letting labels drift. If a loose powder is missing the required inhalation cautionary statements that have applied since 2024, that is a current compliance gap, not a future one.
Frequently asked questions
Does the talc listing mean I have to stop selling talc products in Canada?
No. Nothing in the order requires you to stop selling, reformulate or relabel a talc product today. The order adds talc to Schedule 1, which gives the ministers the authority to propose risk management instruments. Obligations will arrive through those instruments, each of which will be published and open for a 60-day comment period before it is finalised.
Which of my products are most likely to face restrictions?
Loose powder products that can be inhaled, such as baby powder, body powder and loose face powder, and products used in the genital area, such as body powder, diaper and rash creams, genital antiperspirants and deodorants, body wipes, bath bombs and bubble bath. Pressed powders, foot powder and dry shampoo were assessed and not identified as a concern.
Is talc a carcinogen under this decision?
The decision rests on two findings: non-cancer lung effects from inhalation of loose powders, and an association between perineal exposure and ovarian cancer that the screening assessment described as indicative of a causal effect. Talc met the human health criterion under paragraph 64(c) of CEPA. Companies should describe the finding accurately and avoid overstating or understating it.
What is the Cosmetic Ingredient Hotlist and how does it connect to this?
The Cosmetic Ingredient Hotlist is Health Canada's administrative list of ingredients prohibited or restricted in cosmetics. Health Canada's risk management approach proposes to modify the existing talc entry to further reduce exposure. The talc entry was already updated in May 2024 with cautionary statements for loose powder cosmetics, so the next change will build on that foundation.
Do I need to do anything for natural health products that contain talc?
Yes, treat them in the same review. Health Canada proposes to modify the Natural Health Products Ingredients Database entries and applicable monographs for talc. Confirm your product licences reflect current talc content and that applicable monograph cautionary statements already appear on your labels.
How long do we have before the rules change?
There is no single deadline. The risk management approach set planned outer limits of up to 24 months to publish proposed instruments and up to 18 months after each proposal to finalise it. Treat proposed Hotlist and NHPID changes as imminent, plan for a 60-day comment period on each, and confirm current status against the Canada Gazette before relying on any specific date.
How MFLRC can help
MF License and Regulatory Consultants helps cosmetic, natural health product and non-prescription drug companies turn a regulatory signal like the talc listing into a controlled plan rather than a fire drill. Our team maps your portfolio, interprets the risk management approach for your specific products, and builds the documentation that stands up to Health Canada scrutiny and retailer due diligence.
We support clients with talc portfolio screening across cosmetics, natural health products and non-prescription drugs, Cosmetic Notification Form updates, natural health product licence amendments, reformulation and labelling roadmaps aligned to the Cosmetic Ingredient Hotlist, gap assessments, standard operating procedure development, and ongoing regulatory intelligence so that the next ingredient decision does not catch you off guard. Where cosmetics also move into the United States, we align Canadian work with MoCRA registration and listing requirements.
Do any of your powders, creams or wipes contain talc? Book a talc portfolio screening with MFLRC. We map every stock keeping unit against the planned Hotlist and natural health product changes and give you a reformulation and labelling plan before the rules land.
Conclusion
The addition of talc to Schedule 1 of CEPA on 4 November 2026 is not a ban, but it is the starting gun. Health Canada has told the market where it is heading: tighter controls on loose powders that can be inhaled and on products used in the perineal area, delivered through the Cosmetic Ingredient Hotlist and the Natural Health Products Ingredients Database. Companies that inventory their talc products now, screen by exposure route, keep their labels current and engage during the comment periods will move through the coming changes in control. Companies that wait for the final instruments will be reformulating and relabelling under pressure. The lowest cost action available today is a simple one: find out where talc sits in your portfolio and build the plan.
Sources and references
- Order Adding a Toxic Substance to Part 2 of Schedule 1 to CEPA, 1999: SOR/2026-222 (Canada Gazette, Part II)
- Environment and Climate Change Canada: Risk management approach for talc
- Government of Canada: Screening assessment for talc
- Health Canada: Talc information sheet
- Health Canada: Cosmetic Ingredient Hotlist
Downloadable Resource
Talc Product Screening Checklist (Cosmetics and NHP)
A one-page branded checklist to inventory your talc products, flag them by exposure route, and build a reformulation and labelling plan before the Hotlist and NHPID changes land.
File: MFLRC-Talc-Screening-Checklist.pdf
Share with others
Tags
